RecruitingPhase 4NCT06998875
A Prospective Cohort Study on Primary Cutaneous Amyloidosis
Studying Primary cutaneous amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Army Medical University, China
- Principal Investigator
- Rui Yin, MDDepartment of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University)
- Intervention
- Tofacitinib and Acitretin Capsules.(drug)
- Enrollment
- 56 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2025
Study locations (1)
- Department of Dermatology, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, Chongqing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06998875 on ClinicalTrials.gov